Ceftizoxime
Ceftizoxime is a third-generation cephalosporin available for parenteral administration. Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
![]() | |
Clinical data | |
---|---|
Trade names | Cefizox |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a684043 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.210.846 ![]() |
Chemical and physical data | |
Formula | C13H13N5O5S2 |
Molar mass | 383.40 g·mol−1 |
Synthesis
Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.
![](../I/m/Ceftizoxime_synthesis.svg.png)
Ceftizoxime synthesis:[1]
gollark: FOUR of them? Dark sorcery.
gollark: The forum post is less generic, and I can't fit much more into hub text, sadly...
gollark: Seriously? 13 offers in 20 minutes? I am going to have to sort through a lot of stuff.
gollark: Neat, hatching.club has a new UI.
gollark: Is the site being really slow for anyone else?
References
- T. Takaya et al., DE 2810922; eidem, U.S. Patent 4,427,674 (1978, 1984 both to Fujisawa).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.